Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA yield is N/A as of 2026-10-06T15:37:05.963Z.
Calculation as of: 2026-10-06T15:37:05.963Z.
Quote observation: 2026-10-06T15:35:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4b900084dfad819c514917b73a3910c9d2e92354b8183d11bfa5ab73513aed11
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EBITDA YIELD
N/A
SeaStar Medical Holding Corporation
Market Cap
$9.17M
EBITDA Yield
N/A
| NAME | MARKET CAP | EBITDA YIELD |
|---|---|---|
| SeaStar Medical Holding Corporation (ICU) | $9.17M | N/A |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $9.21M | N/A |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.29M | N/A |
| MetaVia Inc. (MTVA)vs › | $9.68M | N/A |
| Ainos, Inc. (AIMD)vs › | $9.80M | N/A |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.53M | N/A |
| DataMEDS AI, Inc. (MEDS)vs › | $8.30M | N/A |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.05M | N/A |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $10.18M | N/A |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.15M | N/A |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
